CClinicalTrials.gg
Not yet recruitingNCT07577297KT-Cerv-WUpdated May 11, 2026

Comparative Effects of Kinesio Taping on Cervical Pain in Climacteric Women

An interventional study of Intervention 1- Neuromuscular Taping - Y-strip and Intervention 2 - Neuromuscular Taping - Star-shape in Climacteric Women and Nonspecific Cervical Pain, sponsored by University of Valencia. Not yet recruiting. Open to female participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by University of Valencia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
Female
01

Study summary

This randomized controlled clinical trial aims to evaluate the effects of neuromuscular taping on cervical pain and health-related quality of life in climacteric women with non-specific chronic neck pain. Two taping techniques ("Y-strip" and "star-shape") will be compared with a control group receiving no intervention.

Participants will be randomly allocated to one of three groups following concealed allocation. The interventions will be applied to the cervicodorsal region (centered at C7) by an experienced physiotherapist over a 3-week period, with taping changes performed weekly. A 4-week total follow-up period will be included.

Primary and secondary outcomes will assess pain intensity, pressure pain threshold, cervical disability, cranio-cervical angle, pain perception, body satisfaction, and health-related quality of life. Measurements will be collected at baseline, weekly during the intervention, and at one-week post-intervention follow-up.

The study is designed to provide evidence on the effectiveness and feasibility of two non-invasive neuromuscular taping approaches in the management of chronic non-specific cervical pain in middle-aged women.

Read the detailed description

This randomized controlled clinical trial is designed to investigate the effects of neuromuscular taping on pain, functional outcomes, and health-related quality of life in climacteric women with non-specific chronic cervical pain. The study compares two different neuromuscular taping applications ("Y-strip" and "star-shape") with a no-intervention control group.

Eligible participants will be women aged 45-65 years with non-specific cervical pain lasting more than three months, presenting mechanical pain characteristics and without clinical signs of specific pathology. After screening and baseline assessment, participants will be randomly allocated to one of the three study groups using a computer-generated randomization sequence with allocation concealment via sealed opaque envelopes.

Interventions will be applied to the cervicodorsal region, centered at the C7 vertebra, by an experienced physiotherapist following standardized protocols. The "Y-strip" technique will target the posterior cervical extensor muscles with directional and cross-taping components, while the "star-shape" technique will consist of four I-strips applied in a radial configuration over the cervicodorsal region. Tape will be replaced every 7 days during a 3-week intervention period. Participants in the control group will continue their usual daily activities without intervention.

Outcome measures will be assessed at five time points: baseline, week 1, week 2, week 3, and one-week post-intervention follow-up (week 4). The primary outcome is cervical pain intensity measured using an 11-point Numerical Rating Scale. Secondary outcomes include pressure pain threshold (measured in cervical and suboccipital muscles using algometry), cranio-cervical angle (assessed in seated and standing positions), neck disability (Neck Disability Index), pain perception (McGill Pain Questionnaire), body satisfaction and self-perception, and health-related quality of life (SF-8 Health Survey).

Pressure pain threshold data will be obtained through three repeated measurements per site and averaged for analysis, including a composite bilateral muscle score. The SF-8 will provide physical and mental component summaries of health status.

The study will employ a blinded outcome assessor, intention-to-treat analysis, and standardized measurement procedures. Participants will be blinded to group allocation, and medication use will not be restricted, although it will be recorded throughout the study period.

This trial aims to provide high-quality evidence regarding the clinical effectiveness of neuromuscular taping as a conservative intervention for chronic non-specific cervical pain and to determine whether different taping configurations produce differential therapeutic effects.

02

Conditions studied

  • Climacteric Women
  • Nonspecific Cervical Pain

Browse trials for

Keywords

  • Kinesio Taping
  • Cervical Pain
  • Climacteric Women
03

In context

Neck Pain

1,232 studies on the registry are indexed under Neck Pain; 255 are open to participants now.

This study's planned enrollment of 50 is close to the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

University of Valencia is the lead sponsor of 349 studies on the registry; 73 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

Female participants aged 45-65 years Non-specific musculoskeletal or osteoarticular cervical pain lasting more than 3 months Mechanical neck pain characteristics (pain influenced by movement or posture; absence of persistent non-mechanical nocturnal pain) Ability to understand the study procedures and provide written informed consent No clinical history or signs suggestive of specific cervical pathology

Exclusion criteria

Exclusion Criteria:

Presence of any red flags Recent cervical trauma History of cancer or presence of constitutional symptoms (e.g., unexplained weight loss, fever, systemic malaise) Signs of infection or immunosuppression-related pain Active inflammatory disease Suspected vascular origin of symptoms (e.g., vertigo with cervical rotation, diplopia, dysarthria, vertebrobasilar symptoms, arterial dissection signs) Severe neurological involvement (e.g., progressive radiculopathy or signs of myelopathy) Relevant findings in previous imaging studies attributable to pain (routine imaging not required; only existing studies will be reviewed) Cervical surgery within the past 12 months Severe systemic diseases affecting the musculoskeletal system

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Arm 1

    Participants will be allocated to neuromuscular taping using a "Y-strip" configuration applied to the cervicodorsal region.

    Other: Intervention 1- Neuromuscular Taping - Y-strip

  • Experimental
    Arm 2

    Participants will be allocated to neuromuscular taping using a "star-shape" configuration applied to the cervicodorsal region.

    Other: Intervention 2 - Neuromuscular Taping - Star-shape

  • No intervention
    Arm 3

Interventions

  • OtherIntervention 1- Neuromuscular Taping - Y-strip

    Neuromuscular taping will be applied over the cervicodorsal region centered at C7. A Y-shaped tape will be placed over the posterior cervical extensor muscles with approximately 15-25% tension, plus an additional perpendicular I-strip over the mid-cervical region (C3-C6). Application will be performed in specific cervical positions to optimize muscle targeting. The tape will be replaced every 7 days. The intervention period will last 3 weeks, followed by 1 week of follow-up without intervention.

  • OtherIntervention 2 - Neuromuscular Taping - Star-shape

    Neuromuscular taping will be applied over the cervicodorsal region centered at C7. Four I-strips will be placed with approximately 25% tension forming a star-shaped configuration over the treatment area. The tape will be replaced every 7 days. The intervention period will last 3 weeks, followed by 1 week of follow-up without intervention.

06

What researchers measure

Primary outcomes

  1. Cervical pain intensity

    Cervical pain intensity will be assessed using an 11-point Numerical Rating Scale (NRS), where 0 indicates no pain and 10 indicates worst imaginable pain. Participants will rate their average cervical pain over the previous week.

    Time frame: Baseline, week 1, week 2, week 3, and week 4 (follow-up)

Secondary outcomes

  1. Pressure pain threshold (PPT)

    Pressure pain threshold will be measured bilaterally in the upper trapezius, levator scapulae, and suboccipital muscles using a digital algometer (Wagner FDK 20). Three measurements per site will be recorded and averaged. A composite score will be calculated.

    Time frame: Baseline, week 1, week 2, week 3, and week 4 (follow-up)

  2. Cranio-cervical angle

    The cranio-cervical angle will be measured in seated and standing positions as the angle between a line from C7 to the tragus and a horizontal reference line through C7.

    Time frame: Baseline, week 3, and week 4 (follow-up)

  3. Neck disability

    The Neck Disability Index (NDI) is a 10-item questionnaire assessing self-reported disability related to cervical pain. Higher scores indicate greater disability.

    Time frame: Baseline, week 3, and week 4 (follow-up)

  4. Pain perception

    McGill Pain Questionnaire (short form). Pain perception will be assessed using the short-form McGill Pain Questionnaire, including Pain Rating Index (PRI), Present Pain Intensity (PPI), Number of Words Chosen (NWC), and Visual Analog Scale (VAS).

    Time frame: Baseline, week 3, and week 4 (follow-up)

  5. Body satisfaction and self-perception

    Body Satisfaction and Global Self-Perception Questionnaire (QSCPGSe). This questionnaire evaluates vitality, aesthetic perception, cognitive discomfort, and affective discomfort. Higher scores indicate greater body satisfaction.

    Time frame: Baseline, week 3, and week 4 (follow-up)

  6. Health-related quality of life

    SF-8 Health Survey. The SF-8 assesses eight domains of health-related quality of life (general health, physical functioning, role physical, bodily pain, vitality, social functioning, role emotional, and mental health). Physical (PCS) and mental (MCS) summary scores will be derived.

    Time frame: Baseline, week 3, and week 4 (follow-up)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to privacy and data protection considerations.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07577297
Lead sponsor
University of Valencia
Responsible party
GEMMA V ESPÍ LÓPEZ, PhD (Principal Investigator, University of Valencia) — Principal investigator
First posted
May 11, 2026
Start date
May 20, 2026 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
May 11, 2026

Study contacts

Gemma Victoria Espi Lopez, PhD
Contact
gemma.espi@uv.es
+34651948635

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion